Institutional members access full text with Ovid®

Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices

Knappich, Moritza; Hörz-Sagstetter, Susannea,b; Schwerthöffer, Dirka; Leucht, Stefana; Rentrop, Michaela

International Clinical Psychopharmacology: July 2014 - Volume 29 - Issue 4 - p 224–228
doi: 10.1097/YIC.0000000000000021
Original Articles

Pharmacotherapy still seems to play a major role in the treatment of patients suffering from borderline personality disorder (BPD). However, little is known about psychiatrists’ detailed perspective on indication and significance of medication. A total of 233 psychiatrists in the city of Munich and in Upper Bavaria were asked by questionnaire about their treatment habits in the medical treatment of patients with BPD. One hundred and forty-one psychiatrists answered the questionnaire (60.5%). In total, 94% of BPD patients were treated with psychotropic medication. Psychiatrists predominantly saw an indication to prescribe antidepressants (98%), followed by antipsychotics, mood stabilizers, and benzodiazepines. Citalopram/escitalopram and quetiapine were mentioned most frequently. The results are discussed in conjunction with the international guidelines for the treatment of BPD.

aDepartment of Psychiatry and Psychotherapy, Technical University of Munich

bDepartment of Psychology, Ludwig Maximilians University Munich, Munich, Germany

Correspondence to Michael Rentrop, MD, Department of Psychiatry and Psychotherapy, Technical University of Munich, Ismaningerstr. 22, DE-81675 Munich, Germany Tel: +49 894 140 4265; fax: +49 894 140 4888; e-mail: michael.rentrop@lrz.tu-muenchen.de

Received June 5, 2013

Accepted October 23, 2013

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins